SOX2 and squamous lung cancer (360G-Wellcome-097143_Z_11_Z)
In the UK, squamous lung cancer (SQC) accounts for approximately 40% of cases. There is accumulating evidence that SOX2 may play a driving role in this common disease. This proposal will test the hypothesis that dysregulated expression of SOX2 is a critical event in the initiation and maintenance of squamous lung cancer (SQC). My aims are: 1. To establish the molecular context in which SOX2 dysregulation occurs in the pathogenesis of SQC. I have developed a unique, single molecule digital PCR protocol to facilitate a comprehensive and parallel survey of somatic copy-number variation and sequence mutations in microdissected archived precancer lesions. 2. To establish the effect of SOX2 dysregulation in an organotypic model of bronchial dysplasia. I will establish a 3-Dimensional organotypic model of bronchial dysplasia in which SOX2 overexpression can be reversibly activated, and the effect of this and potentially co-operating genetic lesions can be interrogated. 3. To develop a novel mouse model of SQC based on SOX2 dysregulation targeted to the basal stem cells of the adult mouse trachea. This state-of-the-art genetically engineered mouse will feature the ability to reversibly and sporadically activate SOX2 in the most plausible cell of origin of squamous lung cancer.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 875280 |
Applicant Surname | McCaughan |
Approval Committee | Clinical Interview Committee |
Award Date | 2011-12-08T00:00:00+00:00 |
Financial Year | 2011/12 |
Grant Programme: Title | Intermediate Clinical Fellowship |
Internal ID | 097143/Z/11/Z |
Lead Applicant | Dr Frank McCaughan |
Partnership Value | 875280 |
Planned Dates: End Date | 2017-05-01T00:00:00+00:00 |
Planned Dates: Start Date | 2012-05-02T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |
Sponsor(s) | Prof Gerard Evan |